Page last updated: 2024-10-19

nitrites and Liver Cirrhosis

nitrites has been researched along with Liver Cirrhosis in 56 studies

Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)

Liver Cirrhosis: Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules.

Research Excerpts

ExcerptRelevanceReference
"The aims of this study were to examine the plasma nitrate/nitrite (NOx; two end products of nitric oxide metabolism) and endothelin-1 (ET-1) concentrations in patients with liver cirrhosis, and to investigate whether there is a relationship between these two vasoactive parameters and the course of disease."7.73Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis. ( Canbaz, M; Curgunlu, A; Erten, N; Karan, MA; Tascioglu, C; Vural, P, 2005)
" Increased levels of endothelin 1 (ET-1) and nitrites and nitrates (NOx, the end products of NO metabolism) have been reported in hepatocellular carcinoma (HCC), but the balance has not been studied."7.71Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma. ( Kouroumalis, A; Kouroumalis, E; Notas, G; Valatas, V; Xidakis, C, 2001)
"We measured plasma nitrites/nitrates as being representative for NO release in blood of patients with chronic hepatitis C without cirrhosis (n = 20), cirrhosis of different aetiologies (n = 30) including HCV, HCC (n = 22) and in healthy controls (n = 8), by an enzyme-linked immunosorbent assay."7.70Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. ( Hayes, PC; Moussa, YI; Plevris, JN, 2000)
"Methylene blue (MB) has been used as a vasopressor in sepsis and acute liver failure."6.70The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. ( Baumann, J; Bellamy, MC; Gedney, JA; Koelzow, H; Snook, NJ, 2002)
" However, acute and chronic administration of L-NAME did not change HE scores in cirrhotic rats."5.46Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats. ( Dehpour, AR; Gharedaghi, MH; Ghiassy, B; Javadi-Paydar, M; Norouzi-Javidan, A; Rahimi, N, 2017)
"To investigate possible abnormalities of vasoactive compounds, nitrative stress, and antioxidant activity of paraoxonase (PONa) in human hepatopulmonary syndrome (HPS), we determined endothelin-1 (ET), nitric oxide (NOx) metabolites, PONa alongside crude plasma nitrotyrosine (NT) as surrogate marker of nitrative stress."3.83Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome. ( Ames, PR; Amitrano, L; Arcaro, A; Batuca, JR; Gentile, F; Guardascione, M, 2016)
"This study aimed to determine whether serum levels of nitric oxide metabolites (nitrates and nitrites) correlate with renal dysfunction in patients with liver cirrhosis and, moreover, to assess nitric oxide metabolite (NOx) power for predicting hepatorenal syndrome (HRS) in such patients."3.80Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis? ( Abdelkader, NA; Mahmoud, WA; Mansor, A, 2014)
"Cyclic GMP (cGMP) concentration is increased in plasma of patients with liver cirrhosis."3.73Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis. ( Del Olmo, JA; Felipo, V; Kosenko, E; Montoliu, C; Rodrigo, JM; Serra, MA, 2005)
"The aims of this study were to examine the plasma nitrate/nitrite (NOx; two end products of nitric oxide metabolism) and endothelin-1 (ET-1) concentrations in patients with liver cirrhosis, and to investigate whether there is a relationship between these two vasoactive parameters and the course of disease."3.73Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis. ( Canbaz, M; Curgunlu, A; Erten, N; Karan, MA; Tascioglu, C; Vural, P, 2005)
" Increased levels of endothelin 1 (ET-1) and nitrites and nitrates (NOx, the end products of NO metabolism) have been reported in hepatocellular carcinoma (HCC), but the balance has not been studied."3.71Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma. ( Kouroumalis, A; Kouroumalis, E; Notas, G; Valatas, V; Xidakis, C, 2001)
"We measured plasma nitrites/nitrates as being representative for NO release in blood of patients with chronic hepatitis C without cirrhosis (n = 20), cirrhosis of different aetiologies (n = 30) including HCV, HCC (n = 22) and in healthy controls (n = 8), by an enzyme-linked immunosorbent assay."3.70Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma. ( Hayes, PC; Moussa, YI; Plevris, JN, 2000)
"Minimal hepatic encephalopathy (MHE) is common in cirrhosis but its pathophysiologic basis remains undefined."2.73Role of ammonia and inflammation in minimal hepatic encephalopathy. ( Jalan, R; Olde Damink, SW; Shawcross, DL; Wright, G, 2007)
"Methylene blue (MB) has been used as a vasopressor in sepsis and acute liver failure."2.70The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation. ( Baumann, J; Bellamy, MC; Gedney, JA; Koelzow, H; Snook, NJ, 2002)
"Dietary nitrite suppressed liver fibrosis in the rats by reducing oxidative stress, as measured using the protein levels of nicotinamide adenine dinucleotide phosphate oxidase components and inflammatory cell accumulation in the liver."1.72Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study. ( Kasono, K; Kitamori, K; Kobayashi, J; Kono, Y; Ohtake, K; Shiba, S; Sonoda, K, 2022)
"Treatment with bezafibrate or pioglitazone decreased the α-SMA expression."1.62Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats. ( Abdelrahman, AM; El-Tahawy, NF; Ibrahim, SA; Mohamed, MZ, 2021)
" However, acute and chronic administration of L-NAME did not change HE scores in cirrhotic rats."1.46Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats. ( Dehpour, AR; Gharedaghi, MH; Ghiassy, B; Javadi-Paydar, M; Norouzi-Javidan, A; Rahimi, N, 2017)
"Oxidative stress, liver fibrosis and angiogenesis may be implicated in n-TiO2-induced liver toxicity."1.42Potential antifibrotic and angiostatic impact of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury. ( Abdelazim, SA; Ali, SA; Darwish, HA; Kadry, MO; Rizk, MZ, 2015)
"Nineteen patients with liver cirrhosis and Helicobacter pylori gastritis were included."1.35The effect of decrease in serum nitric oxide concentration on portal hemodynamics after Helicobacter pylori treatment: an open-label pilot study. ( Gümürdülü, Y; Ozer, B; Pourbagher, MA; Serin, E; Tamer, L; Yilmaz, U, 2008)
"Gallstones were common in patients with liver cirrhosis and the prevalence increased with the progression of liver diseases."1.31Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation. ( Chang, FY; Chu, CJ; Hwang, SJ; Lee, FY; Lee, SD; Li, CP; Lin, HC; Lu, RH, 2000)
"Patients with liver cirrhosis have a nocturnal worsening of hemodynamic parameters that has been associated with an increased risk of variceal bleeding at nighttime."1.31Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients. ( Catalan, R; Cereto, F; Esteban, R; Genesca, J; Gonzalez, A; Guardia, J; Marti, R; Martinez, M; Segura, R; Torregrosa, M, 2000)
"Liver cirrhosis is associated with enlarged right cardiac chambers."1.31Modification of cardiac function in cirrhotic patients with and without ascites. ( De Castro, S; Fiore, P; Funaro, S; Lionetti, R; Masini, A; Merli, M; Pulcinelli, G; Riggio, O; Valeriano, V, 2000)

Research

Studies (56)

TimeframeStudies, this research(%)All Research%
pre-19904 (7.14)18.7374
1990's11 (19.64)18.2507
2000's24 (42.86)29.6817
2010's14 (25.00)24.3611
2020's3 (5.36)2.80

Authors

AuthorsStudies
Sonoda, K1
Kono, Y1
Kitamori, K1
Ohtake, K1
Shiba, S1
Kasono, K1
Kobayashi, J1
Alam, F1
Kharya, AK1
Srivastav, RK1
Akhtar, J1
Khan, MI1
Ahmad, M1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Huang, L2
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T1
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
Liu, S1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Yu, Y2
Han, J2
Zhang, C3
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Wang, C2
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S1
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Xu, H2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Li, J7
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y3
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Zhou, C1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C2
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Lee, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y1
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Xue, H1
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Xia, Y1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Ibrahim, SA1
Mohamed, MZ1
El-Tahawy, NF1
Abdelrahman, AM1
Rahimi, N2
Hassanipour, M1
Allahabadi, NS1
Sabbaghziarani, F1
Yazdanparast, M1
Dehpour, A1
Farahmand, F1
Eshagh Roze, M1
Shams, S1
Ghajarzadeh, M1
Mohammadi, B1
Hernández-Muñoz, R1
Olguín-Martínez, M1
Aguilar-Delfín, I1
Sánchez-Sevilla, L1
García-García, N1
Díaz-Muñoz, M1
Mahmoud, WA1
Abdelkader, NA1
Mansor, A1
Abdelazim, SA1
Darwish, HA1
Ali, SA1
Rizk, MZ1
Kadry, MO1
Ames, PR1
Guardascione, M1
Batuca, JR1
Arcaro, A1
Gentile, F1
Amitrano, L1
Bottari, NB1
Mendes, RE1
Lucca, NJ1
Schwertz, CI1
Henker, LC1
Olsson, DC1
Piva, MM1
Sangoi, M1
Campos, LP1
Moresco, RN1
Jaques, JA1
Da silva, AS1
Mahmoodi, S1
Rahmatollahi, M1
Shahsavari, F1
Shafaroodi, H1
Grayesh-Nejad, S1
Dehpour, AR2
Ghiassy, B1
Javadi-Paydar, M1
Gharedaghi, MH1
Norouzi-Javidan, A1
Lee, S1
Son, SC1
Han, MJ1
Kim, WJ1
Kim, SH1
Kim, HR1
Jeon, WK1
Park, KH1
Shin, MG1
Serin, E1
Pourbagher, MA1
Gümürdülü, Y1
Tamer, L1
Ozer, B1
Yilmaz, U1
Cariello, R1
Federico, A1
Sapone, A1
Tuccillo, C1
Scialdone, VR1
Tiso, A1
Miranda, A1
Portincasa, P1
Carbonara, V1
Palasciano, G1
Martorelli, L1
Esposito, P1
Cartenì, M1
Del Vecchio Blanco, C1
Loguercio, C1
Annie-Jeyachristy, S1
Geetha, A1
Surendran, R1
Sundaram, A1
Lavanya, K1
Kumar, SJ1
Prakash, SA1
Ergün, Y2
Kurutaş, EB1
Ozdil, B1
Güneşaçar, R1
Afzelius, P1
Bazeghi, N1
Bie, P1
Bendtsen, F1
Vestbo, J1
Møller, S1
Naffaa, M1
Abu-Saleh, N1
Awad, H1
Khamaysi, I1
Karram, T1
Azzam, ZS1
Abassi, Z1
Bishara, B1
McNaughton, L1
Puttagunta, L1
Martinez-Cuesta, MA1
Kneteman, N1
Mayers, I1
Moqbel, R1
Hamid, Q1
Radomski, MW1
Mohammed, NA1
Abd El-Aleem, S1
Appleton, I1
Maklouf, MM1
Said, M1
McMahon, RF1
Yang, YY2
Lin, HC3
Lee, WC2
Huang, YT2
Hou, MC2
Lee, FY3
Chang, FY3
Lee, SD3
FINZI, B1
CATTANEO, A1
Tahan, V1
Avsar, E2
Karaca, C1
Uslu, E1
Eren, F1
Aydin, S1
Uzun, H1
Hamzaoglu, HO1
Besisik, F1
Kalayci, C1
Okten, A1
Tozun, N2
Kotzampassi, K1
Metaxas, G1
Paramythiotis, D1
Pidonia, I1
Rekka, H1
Karamouzis, M1
Eleftheriadis, E1
Coll, S1
Vila, MC1
Molina, L1
Gimenez, MD1
Guarner, C2
Solà, R1
Güney Duman, D1
Tüney, D1
Bilsel, S1
Benli, F1
Karan, S1
Ozdogan, O1
Montoliu, C1
Kosenko, E1
Del Olmo, JA1
Serra, MA1
Rodrigo, JM1
Felipo, V1
Curgunlu, A1
Vural, P1
Canbaz, M1
Erten, N1
Karan, MA1
Tascioglu, C1
Engin, A1
Dinçer, S1
Ercan, SZ1
Memiş, L1
Bukan, N1
Bozkurt, S1
Shawcross, DL1
Wright, G1
Olde Damink, SW1
Jalan, R1
Torun, S1
Dolar, E1
Yilmaz, Y1
Keskin, M1
Kiyici, M1
Sinirtas, M1
Sarandol, E1
Gurel, S1
Nak, SG1
Gulten, M1
Gagnon, O1
Gertman, PM1
Iber, FL1
Soriano, G1
Tomas, A1
Bulbena, O1
Novella, MT1
Balanzo, J1
Vilardell, F1
Mourelle, M1
Moncada, S1
El-Newihi, HM1
Kanji, VK1
Mihas, AA1
Moriyama, A1
Masumoto, A1
Nanri, H1
Tabaru, A1
Unoki, H1
Imoto, I1
Ikeda, M1
Otsuki, M1
Rolla, G1
Brussino, L1
Colagrande, P1
Dutto, L1
Polizzi, S1
Scappaticci, E1
Bergerone, S1
Morello, M1
Marzano, A1
Martinasso, G1
Salizzoni, M1
Bucca, C1
Angeli, P1
Volpin, R1
Piovan, D1
Bortoluzzi, A1
Craighero, R1
Bottaro, S1
Finucci, GF1
Casiglia, E1
Sticca, A1
De Toni, R1
Pavan, L1
Gatta, A1
Sánchez-Rodríguez, A1
Criado, M1
Rodríguez-López, AM1
Esteller, A1
Martín de Arriba, A1
López-Novoa, JM1
Genesca, J2
Gonzalez, A2
Segura, R2
Catalan, R2
Marti, R2
Varela, E1
Cadelina, G1
Martinez, M2
Lopez-Talavera, JC1
Esteban, R2
Groszmann, RJ1
Guardia, J2
Sarela, AI1
Mihaimeed, FM1
Batten, JJ1
Davidson, BR1
Mathie, RT1
Heller, J1
Kristeleit, H1
Brensing, KA1
Woitas, RP1
Spengler, U1
Sauerbruch, T1
Barak, N1
Zemel, R1
Ben-Ari, Z1
Braun, M1
Tur-Kaspa, R1
Acosta, F1
Serrano, E1
Diaz, J1
Carbonell, L1
Sansano, T1
Beltran, R1
Roques, V1
Contreras, RF1
Robles, R1
Bueno, FS1
Ramirez, P1
Parrilla, P1
Moussa, YI1
Plevris, JN1
Hayes, PC1
Hon, WM1
Lee, JC1
Lee, KH1
Li, CP1
Hwang, SJ1
Lu, RH1
Chu, CJ1
Torregrosa, M1
Cereto, F1
Valeriano, V1
Funaro, S1
Lionetti, R1
Riggio, O1
Pulcinelli, G1
Fiore, P1
Masini, A1
De Castro, S1
Merli, M1
Notas, G1
Xidakis, C1
Valatas, V1
Kouroumalis, A1
Kouroumalis, E1
Lee, TY1
La Villa, G1
Barletta, G1
Pantaleo, P1
Del Bene, R1
Vizzutti, F1
Vecchiarino, S1
Masini, E1
Perfetto, F1
Tarquini, R1
Gentilini, P1
Laffi, G1
Koelzow, H1
Gedney, JA1
Baumann, J1
Snook, NJ1
Bellamy, MC1
Taylor, HW1
Lijinsky, W1
Nettesheim, P1
Snyder, CM1
Swinnen, J1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical, Biochemical and Haemodynamic Effects of Large-volume Paracentesis (LVP) in Inflammatory Situations[NCT02799160]22 participants (Actual)Observational2016-10-01Active, not recruiting
Evaluation of the Therapeutic Effect of Rifaximin on Covert Hepatic Encephalopathy With Underlying Small Intestinal Bacterial Overgrowth and Gastrointestinal Dysmotility in Liver Cirrhosis Patients[NCT04244877]Phase 30 participants (Actual)Interventional2021-09-15Withdrawn (stopped due to Study was unable to recruit participants..)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for nitrites and Liver Cirrhosis

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016

Trials

6 trials available for nitrites and Liver Cirrhosis

ArticleYear
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Octreotide in liver cirrhosis: a salvage for variceal bleeding can be a gunshot for kidneys.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:3

    Topics: Adult; Aged; Endothelin-1; Female; Gastrointestinal Agents; Gastrointestinal Hemorrhage; Humans; Hyp

2005
Role of ammonia and inflammation in minimal hepatic encephalopathy.
    Metabolic brain disease, 2007, Volume: 22, Issue:1

    Topics: Adult; Aged; Amino Acids; Ammonia; Biomarkers; C-Reactive Protein; Female; Hepatic Encephalopathy; H

2007
Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients.
    World journal of gastroenterology, 2007, Dec-07, Volume: 13, Issue:45

    Topics: Aged; Ascites; Carboxylic Ester Hydrolases; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitr

2007
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
    Hepatology (Baltimore, Md.), 2001, Volume: 34, Issue:1

    Topics: Aged; Aldosterone; Blood Pressure; Cross-Over Studies; Enzyme Inhibitors; Female; Glomerular Filtrat

2001
The effect of methylene blue on the hemodynamic changes during ischemia reperfusion injury in orthotopic liver transplantation.
    Anesthesia and analgesia, 2002, Volume: 94, Issue:4

    Topics: Blood Pressure; Cardiac Output; Central Venous Pressure; Cyclic GMP; Enzyme Inhibitors; Female; Guan

2002

Other Studies

50 other studies available for nitrites and Liver Cirrhosis

ArticleYear
Beneficial Effects of Dietary Nitrite on a Model of Nonalcoholic Steatohepatitis Induced by High-Fat/High-Cholesterol Diets in SHRSP5/Dmcr Rats: A Preliminary Study.
    International journal of molecular sciences, 2022, Mar-08, Volume: 23, Issue:6

    Topics: Animals; Captopril; Cholesterol; Diet, High-Fat; Disease Models, Animal; Liver; Liver Cirrhosis; Nit

2022
Synergetic Effect of Lupeol and Naringin Against Bile Duct Ligation Induced Cardiac Injury in Rats via Modulating Nitrite Level (eNos) and NF-kB /p65 Expression.
    Drug research, 2023, Volume: 73, Issue:1

    Topics: Animals; Bile Ducts; Fibrosis; Ligation; Liver; Liver Cirrhosis; Liver Diseases; NF-kappa B; Nitrite

2023
Antifibrotic effects of bezafibrate and pioglitazone against thioacetamide-induced liver fibrosis in albino rats.
    Canadian journal of physiology and pharmacology, 2021, Volume: 99, Issue:3

    Topics: Actins; Animals; Bezafibrate; Hepatic Stellate Cells; Liver; Liver Cirrhosis; Liver Function Tests;

2021
Cirrhosis induced by bile duct ligation alleviates acetic acid intestinal damages in rats: Involvements of nitrergic and opioidergic systems.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:3

    Topics: Acetic Acid; Analgesics, Opioid; Animals; Bile Ducts; Enzyme Inhibitors; Intestinal Mucosa; Intestin

2018
Diagnosis of spontaneous bacterial peritonitis in children by reagent strips.
    Acta medica Iranica, 2013, Mar-16, Volume: 51, Issue:2

    Topics: Age Factors; Ascitic Fluid; Bacterial Infections; Biomarkers; Carboxylic Ester Hydrolases; Child; Ch

2013
Oxidant status and lipid composition of erythrocyte membranes in patients with type 2 diabetes, chronic liver damage, and a combination of both pathologies.
    Oxidative medicine and cellular longevity, 2013, Volume: 2013

    Topics: Case-Control Studies; Cholesterol; Cysteine; Diabetes Mellitus, Type 2; Erythrocyte Membrane; Humans

2013
Could serum nitrate and nitrite levels possibly predict hepatorenal syndrome in hepatitis C virus-related liver cirrhosis?
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 2014, Volume: 33, Issue:3

    Topics: Adult; Biomarkers; Case-Control Studies; Female; Forecasting; Hepatitis C, Chronic; Hepatorenal Synd

2014
Potential antifibrotic and angiostatic impact of idebenone, carnosine and vitamin E in nano-sized titanium dioxide-induced liver injury.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2015, Volume: 35, Issue:6

    Topics: Alanine Transaminase; Angiogenesis Inhibitors; Animals; Antioxidants; Aspartate Aminotransferases; C

2015
Nitric oxide metabolites, nitrative stress, and paraoxonase activity in hepatopulmonary syndrome.
    Scandinavian journal of gastroenterology, 2016, Volume: 51, Issue:1

    Topics: Aged; Aryldialkylphosphatase; Biomarkers; Cross-Sectional Studies; Endothelin-1; Female; Hepatopulmo

2016
Oxidative stress associated with pathological lesions in the liver of rats experimentally infected by Fasciola hepatica.
    Experimental parasitology, 2015, Volume: 159

    Topics: Advanced Oxidation Protein Products; Animals; Antioxidants; Fascioliasis; Lipid Peroxidation; Liver;

2015
Increased Salivary Nitrite and Nitrate Excretion in Rats with Cirrhosis.
    Acta medica Iranica, 2015, Volume: 53, Issue:11

    Topics: Animals; Liver Cirrhosis; Male; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitrites; Rats; Rats,

2015
Nitric oxide mediates effects of acute, not chronic, naltrexone on LPS-induced hepatic encephalopathy in cirrhotic rats.
    Canadian journal of physiology and pharmacology, 2017, Volume: 95, Issue:1

    Topics: Animals; Drug Interactions; Hepatic Encephalopathy; Lipopolysaccharides; Liver; Liver Cirrhosis; Mal

2017
Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites.
    World journal of gastroenterology, 2008, Jun-28, Volume: 14, Issue:24

    Topics: Adult; Ascites; Case-Control Studies; Cell Membrane Permeability; Female; Humans; Intestinal Absorpt

2008
The effect of decrease in serum nitric oxide concentration on portal hemodynamics after Helicobacter pylori treatment: an open-label pilot study.
    The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2008, Volume: 19, Issue:3

    Topics: Adult; Aged; Anti-Infective Agents; Female; Helicobacter Infections; Helicobacter pylori; Hemodynami

2008
Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2010, Volume: 42, Issue:3

    Topics: Adult; Age Factors; Aged; Alcoholism; Case-Control Studies; Diabetes Complications; Female; Hepatiti

2010
Level of nitrated proteins in the plasma, platelets and liver of patients with liver cirrhosis.
    Redox report : communications in free radical research, 2009, Volume: 14, Issue:6

    Topics: Adult; Blood Platelets; Citrulline; Female; Humans; Liver; Liver Cirrhosis; Male; Middle Aged; Nitri

2009
Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis.
    Clinics and research in hepatology and gastroenterology, 2011, Volume: 35, Issue:4

    Topics: Adult; Case-Control Studies; Humans; Liver Cirrhosis; Middle Aged; Nitrates; Nitrites; Oxidative Str

2011
Circulating nitric oxide products do not solely reflect nitric oxide release in cirrhosis and portal hypertension.
    Liver international : official journal of the International Association for the Study of the Liver, 2011, Volume: 31, Issue:9

    Topics: Adult; Aged; Biomarkers; Breath Tests; Case-Control Studies; Denmark; Female; Heart Rate; Hemodynami

2011
Acute obstructive jaundice and chronic cirrhosis protect against the adverse renal effects of pneumoperitoneum: role of nitric oxide.
    Surgical endoscopy, 2013, Volume: 27, Issue:7

    Topics: Acute Disease; Animals; Cyclic GMP; Glomerular Filtration Rate; Jaundice, Obstructive; Liver Cirrhos

2013
Distribution of nitric oxide synthase in normal and cirrhotic human liver.
    Proceedings of the National Academy of Sciences of the United States of America, 2002, Dec-24, Volume: 99, Issue:26

    Topics: Blotting, Western; Humans; Immunohistochemistry; In Situ Hybridization; Liver; Liver Cirrhosis; Nitr

2002
Expression of nitric oxide synthase isoforms in human liver cirrhosis.
    The Journal of pathology, 2003, Volume: 200, Issue:5

    Topics: Adult; Aged; Endothelium, Vascular; Female; Humans; Immunoenzyme Techniques; Liver Cirrhosis; Male;

2003
Plasma erythropoietin level in patients with cirrhosis and its relationship to the severity of cirrhosis and renal function.
    Journal of gastroenterology and hepatology, 2003, Volume: 18, Issue:10

    Topics: Anemia; Ascites; Blood Pressure; Cardiac Output; Erythropoietin; Hepatic Veins; Humans; Hypertension

2003
[Spleen contraction with amyl nitrite].
    Minerva medica, 1952, Oct-01, Volume: 43, Issue:79

    Topics: Amyl Nitrite; Humans; Liver Cirrhosis; Nitrites; Spleen

1952
Adrenomedullin in cirrhotic and non-cirrhotic portal hypertension.
    World journal of gastroenterology, 2003, Volume: 9, Issue:10

    Topics: Adrenomedullin; Adult; Female; Humans; Hypertension, Portal; Liver Cirrhosis; Male; Middle Aged; Nit

2003
The influence of continuous seven-day elevated intra-abdominal pressure in the renal perfusion in cirrhotic rats.
    The Journal of surgical research, 2003, Volume: 115, Issue:1

    Topics: Abdomen; Aldosterone; Animals; Blood Pressure; Carbon Tetrachloride; Catheterization; Femoral Artery

2003
Mechanisms of early decrease in systemic vascular resistance after total paracentesis: influence of flow rate of ascites extraction.
    European journal of gastroenterology & hepatology, 2004, Volume: 16, Issue:3

    Topics: Abdomen; Aldosterone; Ascites; Ascitic Fluid; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Ni

2004
Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
    Liver international : official journal of the International Association for the Study of the Liver, 2005, Volume: 25, Issue:4

    Topics: Adult; Aged; Ascites; Atrial Natriuretic Factor; Cells, Cultured; Cyclic GMP; Guanylate Cyclase; Hum

2005
Plasma nitrate/nitrite and endothelin-1 in patients with liver cirrhosis.
    Journal of clinical laboratory analysis, 2005, Volume: 19, Issue:5

    Topics: Adult; Disease Progression; Endothelin-1; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrat

2005
Regulation of fibrogenesis during the early phase of common bile duct obstruction.
    ANZ journal of surgery, 2006, Volume: 76, Issue:7

    Topics: Animals; Cell Proliferation; Cholestasis; Collagen; Common Bile Duct Diseases; Dinoprostone; Disease

2006
Comparison of oral isosorbide and intravenous mannitol as adjuncts to the diuresis of patients with cirrhosis of the liver.
    The American journal of the medical sciences, 1967, Volume: 254, Issue:3

    Topics: Adult; Ascites; Humans; Hydrochlorothiazide; Injections, Intravenous; Isosorbide Dinitrate; Liver Ci

1967
Increased serum nitrite and nitrate levels in patients with cirrhosis: relationship to endotoxemia.
    Hepatology (Baltimore, Md.), 1993, Volume: 18, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Colistin; Endotoxins; Humans; Liver Cirrhosis; Middl

1993
Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
    The American journal of gastroenterology, 1996, Volume: 91, Issue:3

    Topics: Adult; Aged; Esophageal and Gastric Varices; Gastric Mucosa; Humans; Hypertension, Portal; Liver Cir

1996
High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:9

    Topics: Analysis of Variance; Carcinoma, Hepatocellular; Case-Control Studies; Cytotoxicity, Immunologic; Fe

1997
Exhaled nitric oxide and oxygenation abnormalities in hepatic cirrhosis.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:4

    Topics: Adult; Echocardiography; Female; Humans; Liver Cirrhosis; Male; Middle Aged; Nitrates; Nitric Oxide;

1997
Acute effects of the oral administration of midodrine, an alpha-adrenergic agonist, on renal hemodynamics and renal function in cirrhotic patients with ascites.
    Hepatology (Baltimore, Md.), 1998, Volume: 28, Issue:4

    Topics: Administration, Oral; Adrenergic alpha-Agonists; Ascites; Blood Pressure; Cardiac Output; Female; Gl

1998
Increased nitric oxide synthesis and inducible nitric oxide synthase expression in patients with alcoholic and non-alcoholic liver cirrhosis.
    Clinical science (London, England : 1979), 1998, Volume: 94, Issue:6

    Topics: Blotting, Northern; Cardiac Output; Chronic Disease; Endotoxins; Enzyme Activation; Female; Humans;

1998
Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
    The American journal of gastroenterology, 1999, Volume: 94, Issue:1

    Topics: Aged; Aldosterone; Ascites; Blood Pressure; Endotoxins; Female; Hepatic Encephalopathy; Humans; Inte

1999
Hepatic and splanchnic nitric oxide activity in patients with cirrhosis.
    Gut, 1999, Volume: 44, Issue:5

    Topics: Adult; Aged; Female; Humans; Liver; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Nitra

1999
Nitrite and nitrate levels in patients with cirrhosis of the liver: influence of kidney function and fasting state.
    Scandinavian journal of gastroenterology, 1999, Volume: 34, Issue:3

    Topics: Case-Control Studies; Fasting; Female; Humans; Kidney; Liver Cirrhosis; Male; Middle Aged; Nitrates;

1999
Nitric oxide metabolites in decompensated liver cirrhosis.
    Digestive diseases and sciences, 1999, Volume: 44, Issue:7

    Topics: Adult; Aged; Angina Pectoris; Female; Hemoglobins; Humans; Kidney Failure, Chronic; Liver Cirrhosis;

1999
Hemodynamic consequences of oxidative stress following reperfusion during liver transplantation.
    Transplantation proceedings, 1999, Volume: 31, Issue:6

    Topics: Analysis of Variance; Blood Pressure; Hemodynamics; Humans; Liver Cirrhosis; Liver Transplantation;

1999
Plasma nitrites/nitrates in HCV infection and hepatocellular carcinoma.
    European journal of gastroenterology & hepatology, 2000, Volume: 12, Issue:2

    Topics: Adult; Carcinoma, Hepatocellular; Case-Control Studies; Enzyme-Linked Immunosorbent Assay; Female; H

2000
Effect of hemodialysis on plasma nitric oxide levels.
    Artificial organs, 2000, Volume: 24, Issue:5

    Topics: Colorimetry; Cyclic GMP; Female; Follow-Up Studies; Humans; Inflammation Mediators; Kidney Failure,

2000
Evaluation of gallbladder motility in patients with liver cirrhosis: relationship to gallstone formation.
    Digestive diseases and sciences, 2000, Volume: 45, Issue:6

    Topics: Aged; Cholelithiasis; Disease Progression; Eating; Estradiol; Female; Gallbladder; Humans; Liver Cir

2000
Nitric oxide may contribute to nocturnal hemodynamic changes in cirrhotic patients.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:6

    Topics: Aged; Blood Pressure; Circadian Rhythm; Cytokines; Female; Heart Rate; Hemodynamics; Humans; Liver C

2000
Modification of cardiac function in cirrhotic patients with and without ascites.
    The American journal of gastroenterology, 2000, Volume: 95, Issue:11

    Topics: Ascites; Cardiomyopathies; Case-Control Studies; Echocardiography; Echocardiography, Doppler, Color;

2000
Levels of circulating endothelin-1 and nitrates/nitrites in patients with virus-related hepatocellular carcinoma.
    Journal of viral hepatitis, 2001, Volume: 8, Issue:1

    Topics: Carcinoma, Hepatocellular; Endothelin-1; Female; Hepacivirus; Hepatitis B; Hepatitis B virus; Hepati

2001
Adaptive vasodilatory response after octreotide treatment.
    American journal of physiology. Gastrointestinal and liver physiology, 2001, Volume: 281, Issue:1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aorta; Blotting, Western; Cyclooxygenase Inhibitors; Dose-Res

2001
Alteration of tumor response in rat liver by carbon tetrachloride.
    Cancer research, 1974, Volume: 34, Issue:12

    Topics: Aminopyrine; Animals; Carbon Tetrachloride Poisoning; Carcinoma, Hepatocellular; Female; Liver; Live

1974
New colorimetric micromethod for the estimation of gamma-glutamyl transpeptidase activity in biological samples.
    Zeitschrift fur klinische Chemie und klinische Biochemie, 1970, Volume: 8, Issue:6

    Topics: Acyltransferases; Adult; Amides; Aniline Compounds; Biliary Tract Diseases; Buffers; Chemistry, Clin

1970